Tutorials
ReNeuron Group PLC logo

ReNeuron Group PLC

£ 0.26 (0%) Aug 12
P/E:
At Loss
P/B:
1.50
Market Cap:
£ 14.84M ($ 18.02M)
Enterprise V:
£ 851.00K ($ 1.03M)
Volume:
83.91K
Avg Vol (2M):
125.28K
Also Trade In:
Volume:
83.91K
Market Cap £:
14.84M
Market Cap $:
18.02M
PE Ratio:
At Loss
Avg Vol (2-Month):
125.28K
Enterprise Value £:
851.00K
Enterprise Value $:
1.03M
PB Ratio:
1.50
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

ReNeuron Group PLC
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
Description
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and US. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 25.89
Equity-to-Asset 0.57
Debt-to-Equity 0.06
Debt-to-EBITDA -0.05
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -12.12
Distress
Grey
Safe
Beneish M-Score -2.53
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 4.33
9-Day RSI 17.21
14-Day RSI 25.77
6-1 Month Momentum % -27.71
12-1 Month Momentum % -72.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.35
Quick Ratio 2.35
Cash Ratio 2.07
Days Sales Outstanding 476.85

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.6

Financials (Next Earnings Date:2022-11-30 Est.)

LSE:RENE's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 0.403
EPS (TTM) (£) -0.17
Beta 2.18
Volatility % 73.82
14-Day RSI 25.77
14-Day ATR (£) 0.013312
20-Day SMA (£) 0.28225
12-1 Month Momentum % -72.48
52-Week Range (£) 0.25 - 1.35
Shares Outstanding (Mil) 57.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ReNeuron Group PLC Filings

Document Form Filing Date
No Filing Data